Disease modification has been defined in multiple disease areas but no widely accepted definition exists for SLE. Learn about the benefits & why there’s a need to consider therapies that modify the immunologic mechanisms of SLE. Sponsored by GSK USMA https://t.co/GV20emEpki https://t.co/onX7To2zvn

Can SGLT2 Inhibitors Be Protective in Lupus and Vasculitis? SGLT2 inhibitors are all the buzz in the renal world with reports of a renal protective and mortality lowering effects https://t.co/b7YupKPJr7 #MedEd https://t.co/AYPeX360Gv

Amitriptyline and FDA Treatments for Fibromyalgia #MedEd https://t.co/zA4rycnHg4 https://t.co/TxD1jp6XGf

Watch: Lupus Nephritis: The Blind Men and the Kidney with Dr. Joan Merrill Joan Merrill discusses treatment of lupus nephritis. This was previously recorded at RheumNow Live 2022. https://t.co/9GRw5VGTKr https://t.co/PS6aEk1fsx

Visit @RheumNow podcast channel & hear experts from the #SLEEducatorsNetwork review a new framework for defining disease modification in SLE and why there’s a need to consider therapies that modify the immunologic mechanisms of SLE. Sponsored by GSK USMA https://t.co/gsrYmu5ufO https://t.co/Fmt21u3wUN

Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on https://t.co/V10S4oVFsv. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus? https://t.co/iaMQZtzdLm https://t.co/Zu9VwKoCAc

Looking forward to reading/watching the coverage of #EULAR2022 by our outstanding faculty, including Drs., Rachel Tate @uptoTate, Kathryn Dao @KDAO2011, Robert Chao @doctorRBC , Janet Pope @Janetbirdope and Antoni Chan @synovialjoints . https://t.co/oBQCxzdzfF

Join experts from the #SLEEducatorsNetwork to learn more about our current understanding of SLE pathophysiology & why, given its progressive nature, there’s a need to try to change the course of this complex disease. Sponsored by GSK USMA @jeevsmd https://t.co/WkL1lU2JRJ https://t.co/g8iv6WUG5k

Watch: Novel Treatment of SLE Dr. Sonali Narain discusses new insights on existing treatments and newly approved therapy and soon to be approved therapies for SLE. #MedEd https://t.co/7Op3R8IzV1 #MedEdTwitter https://t.co/qBMTbOBmyM

Long COVID Manifestations The acute consequences of a SARS-CoV-2 infection may be bothersome or devastating, but the long-term consequences may lead to so-called "long COVID" syndrome. Long COVID appears to affect up to 20% of those who survive COVID-19. https://t.co/BFgazzEQWl https://t.co/0HyWZ3HcLG

Watch: Treatment Choices in Refractory RA Dr. Cush presents Treatment Choices in Refractory RA, during the RheumNow Live 2022 meeting held in March 2022. #MedEd https://t.co/5wjLyVAS7o https://t.co/dnh8Y5Of4G